CoChat

Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis

Open access

The DOI matches its Crossref record, with a small difference in title or year; 14 of the 14 references it cites were found in a registry or an index.

Abstract

BACKGROUND: In patients with idiopathic deep venous thrombosis, continuing anticoagulant therapy beyond three months is associated with a reduced incidence of recurrent thrombosis during the period of therapy. Whether this benefit persists after anticoagulant therapy is discontinued is controversial. METHODS: Patients with a first episode of idiopathic proximal deep venous thrombosis who had completed three months of oral anticoagulant therapy (with warfarin, in 97 percent of the cases and acenocoumarol in 3 percent) were randomly assigned to the discontinuation of oral anticoagulants or to their continuation for nine additional months. The primary study outcome was recurrence of symptomatic, objectively confirmed venous thromboembolism during at least two years of follow-up. RESULTS: The primary intention-to-treat analysis showed that of 134 patients assigned to continued oral anticoagulant therapy, 21 had a recurrence of venous thromboembolism (15.7 percent; average follow-up, 37.8 months), as compared with 21 of 133 patients assigned to the discontinuation of oral anticoagulant therapy (15.8 percent; average follow-up, 37.2 months), resulting in a relative risk of 0.99 (95 percent confidence interval, 0.57 to 1.73). During the initial nine months after randomization (after all patients received three months of therapy), 1 patient had a recurrence while receiving oral anticoagulant therapy (0.7 percent), as compared with 11 of the patients assigned to the discontinuation of oral anticoagulant therapy (8.3 percent; P=0.003). The incidence of recurrence after the discontinuation of treatment was 5.1 percent per patient-year in patients in whom oral anticoagulant therapy was discontinued after 3 months (95 percent confidence interval, 3.2 to 7.5 percent; average interval since discontinuation, 37.2 months) and 5.0 percent per patient-year in patients who received an additional 9 months of oral anticoagulant therapy (95 percent confidence interval, 3.1 to 7.8 percent; average interval since discontinuation, 29.4 months). None of the recurrences were fatal. Four patients had non-fatal major bleeding during the extended period of anticoagulant therapy (3.0 percent). CONCLUSIONS: In patients with idiopathic deep venous thrombosis, the clinical benefit associated with extending the duration of anticoagulant therapy to one year is not maintained after the therapy is discontinued.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm200107193450302

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 14 references

Research works printed but not linked: 2

  1. 10.2307/2281868 · doi:10.2307/2281868 · Paper page
  2. Mantel N, 1966, Cancer Chemother Rep, 50, 163

Cited by

See all 591

Metadata

Authors
Agnelli, G., Prandoni, P., Santamaria, M. G., Bagatella, P., Iorio, A., Bazzan, M., Moia, M., Guazzaloca, G., Bertoldi, A., Tomasi, C., Scannapieco, G., Ascani, A., Villalta, S., Frulla, M., Mosena, L., Girolami, A., Vaccarino, A., Alatri, A., Palareti, G., Marchesi, M., Ambrosio, G. B., Parisi, R., Doria, S., Steidl, L., Ambrosini, F., Silingardi, M., Ghirarduzzi, A., Iori, I., & Ageno, W.
Affiliations
  • University of Perugia (IT)
  • University of Padua (IT)
  • University of Turin (IT)
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
  • IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
  • Ospedale Santa Chiara (IT)
  • Ospedale di Bolzano (IT)
Venue
New England Journal of Medicine
Published
2001-07-19
Volume
345
Issue
3
Pages
165-169
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2568332688
Cited by
591
References
14
Citations by year
2026: 6 · 2025: 9 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 11 · 2020: 13 · 2019: 17 · 2018: 19 · 2017: 21 · 2016: 27 · 2015: 18 · 2014: 23 · 2013: 24 · 2012: 27
FWCI
32.35
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • IrInSubria (University of Insubria) (submittedVersion, other-oa)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
Keywords
oral anticoagulation, warfarin, acenocoumarol, anticoagulation discontinuation, venous thromboembolism recurrence, proximal deep venous thrombosis, bleeding complications, long-term follow-up, thromboprophylaxis duration, post-thrombotic syndrome
MeSH terms
Acenocoumarol, Administration, Oral, Adolescent, Adult, Aged, Aged, 80 and over, Anticoagulants, Humans, Middle Aged, Recurrence, Time Factors, Warfarin, Treatment Outcome, International Normalized Ratio, Venous Thrombosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis. https://app.cochat.ai/papers/10.1056/nejm200107193450302
The paper
Agnelli, G., Prandoni, P., Santamaria, M. G., Bagatella, P., Iorio, A., Bazzan, M., Moia, M., Guazzaloca, G., Bertoldi, A., Tomasi, C., Scannapieco, G., Ascani, A., Villalta, S., Frulla, M., Mosena, L., Girolami, A., Vaccarino, A., Alatri, A., Palareti, G., . . . Ageno, W. (2001). Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis. New England Journal of Medicine. https://doi.org/10.1056/nejm200107193450302

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.